Part, Chapter, Paragraph
1 II, 5. 5. 3| care and welfare support (Andlin-Sobocki et al, 2005).~Schizophrenia
2 II, 5. 5. 3| expenditures for all diagnosis (Andlin-Sobocki & Rössler, 2005).~In 2004,
3 II, 5. 5. 3| direct costs, as evaluated by Andlin-Sobocki (Figure 5.5.3.3.7), it can
4 II, 5. 5. 3| Saf Health Care 12:18-23.~Andlin-Sobocki P, Jönsson B, Wittchen HU,
5 II, 5. 5. 3| Neurol 12 Suppl 1:1-27.~Andlin-Sobocki P, Rössler W (2002):Health
6 II, 5. 5. 3| Health Bull 13(7):155-8.~Andlin-Sobocki P, & Rössler W (2005):Cost
7 II, 5. 5. 3| billion per year in Europe (Andlin-Sobocki et al, 2005).~
8 II, 5. 5. 3| articles are available (Andlin-Sobocki et al, 2005; Dowding et
9 II, 5. 5. 3| including PD (Figure 5.5.3.6.2) (Andlin-Sobocki et al, 2005). The cost per
10 II, 5. 5. 3| EBC pan-European study (Andlin-Sobocki et al, 2005) also demonstrate
11 II, 5. 5. 3| brain disorders in Europe (Andlin-Sobocki et al, 2005). Parkinson’
12 II, 5. 5. 3| Mov Disord 14(1):21-27.~Andlin-Sobocki P, Jonsson B, Wittchen HU,
13 III, 10. 5. 3| amounted to €132 billion (Andlin-Sobocki et al, 2005). These are
14 III, 10. 5. 3| Health Promotion 15(5):296-320.~Andlin-Sobocki P, Jönsson B, Wittchen H-U,
15 IV, 13. 9 | 13.9. References~ ~Andlin-Sobocki P, Jönsson B, Wittchen HU,
